Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 28, 2016; 22(48): 10631-10642
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10631
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10631
Table 4 Change in pain score for volunteers with moderate or severe abdominal pain at baseline
| Treatment | n | Baseline | Week 12 | Change from baseline | Mean difference for combined active doses | P value |
| mean ± SD | mean ± SD | mean ± SD | 95%CI | |||
| Placebo | 29 | 51.1 (9.3) | 30.3 (22.9) | -20.8 (22.8) | ||
| Low-dose | 36 | 53.6 (10.9) | 24.4 (19.4) | -29.4 (17.9) | -9.5 (-18.8; -0.17) | 0.046 |
| High-dose | 34 | 52.1 (10.7) | 21.9 (20.6) | -31.2 (21.9) |
- Citation: Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22(48): 10631-10642
- URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10631